Trial NCT04279938

View at ClinicalTrials.gov 
Org. Study IDs: REACH - Trial Number pending

Last trial update was posted on 2020-02-21

MeSH Interventions

Pembrolizumab Rituximab

MeSH Conditions

Lymphoma, Large B-Cell, Diffuse

Other Conditions

Relapsed or Refractory Diffuse Large B-cell Lymphoma

Stopping Reasons

Safety data on drug

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID